RecruitingPhase 4NCT04567511
Blood
Mild hemophilia A
1
studies recruiting now
as of 7 Sept 2026
10
studies registered in total
as of 7 Sept 2026
1
countries with a recruiting site
as of 7 Sept 2026
28 Sept 2020
most recent study posted
among recruiting studies
Recruiting trials
Showing the 1 most recently updated recruiting study, as recorded 7 Sept 2026. Live status on each study page.
Search all Mild hemophilia A studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Mild hemophilia A study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Mild hemophilia A
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (F8).
Treatments being studied
20 approved treatments and 15 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Damoctocog Alfa Pegol (Jivi)Approved: Susoctocog Alfa (Obizur)Approved: Marstacimab (Hympavzi)Approved: Turoctocog Alfa Pegol (Esperoct)Approved: Efmoroctocog Alfa (Elocta)Approved: Valoctocogene Roxaparvovec (Roctavian)Approved: Concizumab (Alhemo)Approved: Emicizumab (Hemlibra)Approved: Moroctocog Alfa (Refacto af)Approved: Human Coagulation Factor Viii (Hemofil m)Approved: Eptacog Beta (Activated) (Cevenfacta)Approved: Von Willebrand Factor Human (Von willebrand factor human component of voncento)Approved: Simoctocog Alfa (Nuwiq)Approved: Turoctocog Alfa (Novoeight)Approved: Antihemophilic Factor, Pegylated (Mw 20000) Human Sequence Recombinant (Adynovi)Approved: Tranexamic Acid (Cyklo-f heavy period relief)Approved: Efanesoctocog Alfa (Altuviiio)Approved: Eptacog Alfa (Activated) (Novoseven)Approved: Octocog Alfa (Advate)Approved: Lonoctocog Alfa (Afstyla)
Phase 3Denecimig
Phase 3Giroctocogene Fitelparvovec
Phase 3Fitusiran
Phase 3Anti-Inhibitor Coagulant Complex
Phase 3Vatreptacog Alfa (Activated)
Phase 3Omfiloctocog Alfa
Phase 2/3Thrombin
Phase 2Ataluren (Translarna)
+ 7 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).